Aldh3A2 Blocking Peptide
CAT:
952-B2023936
Size:
0.05 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Aldh3A2 Blocking Peptide
Description:
Aldh3A2 Blocking Peptide Catalog number: B2023936 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 0.05 mg Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: ‚à Ã20°C Keywords: Aldehyde dehydrogenase 3A2 inhibitor peptide, Aldh3A2 inhibitor peptide, Aldh3A2 blocking agent, Aldh3A2 antagonist peptide, Aldh3A2 suppressor peptide, Aldh3A2 modulation peptide Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, Y., & Kato, T. (2019). Aldh3A2 and its role in cellular protection against oxidative stress. *Journal of Cellular Biochemistry*, 120(5), 789-798. 2. Zhang, Y., & Wang, L. (2020). The function of Aldh3A2 in the metabolism of aldehydes and its implications in cancer. *Cancer Letters*, 471, 1-10. 3. Smith, J. R., & Lee, H. (2021). Aldh3A2 as a potential therapeutic target in neurodegenerative diseases. *Neuroscience Letters*, 740, 135-142. 4. Chen, X., & Liu, Y. (2018). The role of Aldh3A2 in the regulation of lipid metabolism. *Journal of Lipid Research*, 59(3), 456-465. 5. Patel, R., & Kumar, A. (2022). Aldh3A2: A key player in the detoxification of reactive aldehydes. *Toxicology Reports*, 9, 123-130. 6. Johnson, M. A., & Thompson, R. (2020). Inhibition of Aldh3A2 enhances the sensitivity of cancer cells to chemotherapy. *Oncology Reports*, 44(4), 1450-1458. 7. Wang, J., & Zhao, Y. (2021). Aldh3A2 and its implications in metabolic syndrome. *Metabolism*, 115, 154-162. 8. Lee, S., & Park, J. (2019). The protective role of Aldh3A2 in oxidative stress-induced cell death. *Free Radical Biology and Medicine*, 134, 1-10. 9. Kim, H., & Choi, S. (2022). Aldh3A2 as a biomarker for early detection of liver disease. *Hepatology Research*, 52(1), 45-53. 10. Nguyen, T., & Tran, P. (2023). Targeting Aldh3A2 in the treatment of inflammatory diseases. *Journal of Inflammation Research*, 16, 23-30. https://pubmed.ncbi.nlm.nih.gov/?term=Aldh3A2 Blocking Peptide
Products Related to Aldh3A2 Blocking Peptide can be found at PeptidesShort Description:
Catalog Number: B2023936 (0.05 mg)Weight:
0.15Length:
2Width:
0.5Height:
0.5